Retatrutide 15mg

Description

Retatrutide is an investigational peptide-based medication being studied for obesity and metabolic conditions. It works by activating three hormone receptors—GLP-1, GIP, and glucagon—which are involved in appetite regulation, energy balance, and glucose metabolism. By influencing these pathways together, retatrutide is designed to reduce appetite, increase energy expenditure, and improve metabolic health. Early clinical trial results have shown significant weight loss and metabolic effects, but it’s important to note that retatrutide is still under investigation and is not FDA-approved for clinical use at this time.